Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

NCT06132503 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Lantern Pharma Inc.